ENTRY       D05364                      Drug
NAME        Parathyroid hormone (human) (USAN);
            Parathyroid hormone (INN);
            ALX 1-11;
            Parathormone;
            PTH;
            Natpara (TN)
PRODUCT     NATPARA (PARATHYROID HORMONE) (Takeda Pharmaceuticals America)
FORMULA     C408H674N126O126S2
EXACT_MASS  9418.9648
MOL_WEIGHT  9424.6158
SEQUENCE    H-Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn
            Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His
            Asn Phe Val Ala Leu Gly Ala Pro Leu Ala Pro Arg Asp Ala Gly Ser
            Gln Arg Pro Arg Lys Lys Glu Asp Asn Val Leu Val Glu Ser His Glu
            Lys Ser Leu Gly Glu Ala Asp Lys Ala Asp Val Asn Val Leu Thr Lys
            Ala Lys Ser Gln-OH
  TYPE      Peptide
CLASS       Hormonal agent
             DG01661  Parathyroid hormone and analog
REMARK      Same as: C16051
            ATC code: H05AA03
            Product: D05364<US>
EFFICACY    Diagnostic (pseudohypoparathyroidism, hypocalcemia), Osteoporosis agent, Parathyroid hormone receptor agonist
  DISEASE   Hypoparathyroidism [DS:H01862]
COMMENT     peptide hormone
            Treatment of osteoporosis, as an antiosteoporotic, in the treatment of bone and mineral disease and disorders, bone metabolism regulator, blood calcium regulator
TARGET      PTH1R [HSA:5745] [KO:K04585]
            PTH2R [HSA:5746] [KO:K04586]
  PATHWAY   hsa04080(5745+5746)  Neuroactive ligand-receptor interaction
            hsa04928(5745)  Parathyroid hormone synthesis, secretion and action
            hsa04961(5745)  Endocrine and other factor-regulated calcium reabsorption
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H05 CALCIUM HOMEOSTASIS
               H05A PARATHYROID HORMONES AND ANALOGUES
                H05AA Parathyroid hormones and analogues
                 H05AA03 Parathyroid hormone
                  D05364  Parathyroid hormone (human) (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Calcium Regulating Hormones
               Parathyroid Hormone
                D05364  Parathyroid hormone (human) (USAN)
            Drug groups [BR:br08330]
             Hormonal agent
              DG01661  Parathyroid hormone and analog
               D05364  Parathyroid hormone (human)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Parathyroid hormone
                PTH1R
                 D05364  Parathyroid hormone (human) (USAN) &lt;US&gt;
                PTH2R
                 D05364  Parathyroid hormone (human) (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05364
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05364
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05364
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D05364
DBLINKS     CAS: 68893-82-3
            PubChem: 47207043
///
